These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7817584)

  • 21. Improving lipid goal attainment: is it enough?
    Gotto AM
    Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383
    [No Abstract]   [Full Text] [Related]  

  • 22. Choosing drug therapy for patients with hyperlipidemia.
    Safeer RS; Lacivita CL
    Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach.
    Baillargeon JP; Lepage S; Larrivée L; Roy MA; Landry S; Maheux P
    Can J Cardiol; 2001 Jul; 17(7):767-8. PubMed ID: 11515497
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacologic treatment of dyslipidemias: Analysis of initiation recommendations and drug selection].
    Davidoff P
    Rev Med Chil; 1991 Dec; 119(12):1423-32. PubMed ID: 9723101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of saponin from Tribulus terrestris on hyperlipidemia].
    Chu S; Qu W; Pang X; Sun B; Huang X
    Zhong Yao Cai; 2003 May; 26(5):341-4. PubMed ID: 14535016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achieving lipid goals in Europe: how large is the treatment gap?
    Schwandt P; Brady AJ
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):431-49. PubMed ID: 15151488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia: treatment with lipid-lowering agents.
    LaRosa JC
    Md Med J; 1988 May; 37(5):401-6. PubMed ID: 3386426
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoproteins HDL and coronary artery disease: a molecular mechanism of fibrate].
    Kaletha K; Chodorowski Z; Anand IS; Rybakowska I; Nagel-Starczynowska G
    Przegl Lek; 2003; 60(4):223-5. PubMed ID: 14569888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing dyslipidemia in adults with diabetes.
    Haffner SM
    Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology of hypolipidemic agents].
    Féry F; Balasse EO
    Rev Med Brux; 1997 Feb; 18(1):26-31. PubMed ID: 9132914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
    Mal' GS
    Klin Med (Mosk); 2004; 82(5):63-6. PubMed ID: 15230046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D; Hamood H; Morad N; Naschitz J
    Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of hyperlipidemia and its treatment].
    Ouellet A
    Union Med Can; 1991; 120(3):238-43. PubMed ID: 1866844
    [No Abstract]   [Full Text] [Related]  

  • 39. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 40. Current drug treatments for lipid management.
    Stone NJ
    Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.